CUAMC
ALNY icon

China Universal Asset Management Company’s Alnylam Pharmaceuticals ALNY Stock Holding History

China Universal Asset Management Company’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.61M Sell
25,269
-1,997
-7% -$602K 0.45% 47
2026
Q1 		$9.02M Buy
27,266
+1,999
+8% +$680K 0.68% 35
2025
Q4 		$10M Buy
25,267
+2,480
+11% +$1.1M 0.77% 28
2025
Q3 		$10.4M Sell
22,787
-5,030
-18% -$2.05M 0.86% 22
2025
Q2 		$9.07M Sell
27,817
-3,154
-10% -$873K 0.85% 24
2025
Q1 		$8.36M Sell
30,971
-8,026
-21% -$2.06M 0.78% 22
2024
Q4 		$9.18M Buy
38,997
+2,657
+7% +$699K 0.86% 22
2024
Q3 		$9.99M Buy
36,340
+9,831
+37% +$2.56M 1.1% 18
2024
Q2 		$6.44M Sell
26,509
-9,313
-26% -$1.47M 0.91% 31
2024
Q1 		$5.35M Buy
35,822
+9,662
+37% +$1.61M 0.68% 39
2023
Q4 		$5.01M Buy
26,160
+22,580
+631% +$3.85M 0.97% 26
2023
Q3 		$634K Sell
3,580
-9,492
-73% -$1.81M 0.18% 100
2023
Q2 		$2.48M Buy
13,072
+9,868
+308% +$1.96M 0.77% 39
2023
Q1 		$642K Sell
3,204
-10,400
-76% -$2.19M 0.22% 85
2022
Q4 		$3.23M Buy
13,604
+12,480
+1,110% +$2.66M 1.3% 21
2022
Q3 		$225K Buy
+1,124
New +$214K 0.09% 92

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

China Universal Asset Management Company's ALNY Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Alnylam Pharmaceuticals (ALNY) stake by 7.3% in Q2 2026, selling an estimated $602K and leaving 25,269 shares worth $7.61M. The position accounts for 0.45% of the portfolio, ranked #47.

China Universal Asset Management Company first reported a position in ALNY in Q3 2022 and has held it in 16 quarters since. The position peaked at $10.4M in Q3 2025. 793 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • China Universal Asset Management Company held 25,269 shares of Alnylam Pharmaceuticals worth $7.61M as of Q2 2026.
  • China Universal Asset Management Company sold 1,997 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $602K.
  • Alnylam Pharmaceuticals made up 0.45% of China Universal Asset Management Company's portfolio in Q2 2026, its #47 holding.
  • China Universal Asset Management Company first reported a position in Alnylam Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's Alnylam Pharmaceuticals position peaked at $10.4M in Q3 2025.
  • 793 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.